Inotiv, Inc. — Director's Dealing 2018

Feb 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2018-02-16

Reporting Person: Downing Philip A (Sr. VP, Preclinical Srvcs.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-16	Common Shares	P	5000	$1.46	Acquired	15765	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. The shares sold were sold in multiple transactions at prices ranging from $1.45 to $1.4594, inclusive. The reporting person undertakes to provide Bioanalytical Systems, Inc., any security holder of Bioanalytical Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.